Pharmacokinetic-Pharmacodynamic Profile of Angiotensin II Receptor Antagonists
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 32 (1) , 1-29
- https://doi.org/10.2165/00003088-199732010-00001
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.Published by Wiley ,1995
- The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.1995
- Effects of Losartan on a Background of Hydrochlorothiazide in Patients With HypertensionHypertension, 1995
- Losartan in Heart FailureCirculation, 1995
- Dose-Response Relationships of ACE Inhibitors and Angiotensin II BlockersEuropean Heart Journal, 1994
- Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.British Journal of Clinical Pharmacology, 1993
- The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices.1992
- Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.1991
- Noninvasive Blood Pressure Monitoring at the Finger for Studying Short Lasting Pressor Responses in ManThe Journal of Clinical Pharmacology, 1990
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973